Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.38 +0.20 (+6.29%)
At close: Sep 29, 2026 · 4:00 PM EDT

Insight Molecular Diagnostics (IMDX) FCF Margin (2020 - 2026)

Updated

Insight Molecular Diagnostics (IMDX) recorded FCF Margin of -4203.77% in Q2 2026, down 2944.50 percentage points from -1259.27% a year earlier but up 21583.73 percentage points from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) FCF Margin (2020 - 2026) Analysis & Trends

On a TTM basis, Insight Molecular Diagnostics' FCF Margin came in at -1856.23% as of Jun 30, 2026, down 1295.95 percentage points year-over-year; for FY2025, it was -625.62%, up 501.70 percentage points from FY2024.

  • Annual FCF Margin has increased for three straight years, with a five-year change of +1611.80 percentage points (FY2020 to FY2025).
  • Across earlier years, FCF Margin came in at -1127.33% in FY2024 (+443.27 pp), -1570.59% in FY2023 (+3639.01 pp), -5209.60% in FY2022 (-3472.21 pp) and -1737.40% in FY2021 (+500.02 pp).
  • Quarterly FCF Margin has ranged from -25787.50% in Q1 2026 to -208.02% in Q4 2021 over the past five years.
  • On a year-over-year basis, FCF Margin has declined for three consecutive quarters, with an average year-over-year change of -2803.68 percentage points over the last eight quarters.
  • Peak year-over-year performance for FCF Margin in the last five years was a gain of 17543.96 percentage points in Q3 2023, against a drop of 25500.04 percentage points in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -25787.50% (Q1 2026), -616.68% (Q4 2025) and -2183.08% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 13.97%
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 15.81%
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 20.19%
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 32.79%
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 13.22%
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 16.07%
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 23.50%
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 12.70%
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 33.60%
10 Insight Molecular Diagnostics 103.74 Mn 27.46 Mn 157,000.00 -4,203.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,203.77%
Mar 31, 2026 -25,787.50%
Dec 31, 2025 -616.68%
Sep 30, 2025 -2,183.08%
Jun 30, 2025 -1,259.27%
Mar 31, 2025 -287.46%
Dec 31, 2024 -374.50%
Sep 30, 2024 -4,884.35%
Jun 30, 2024 -5,931.73%
Mar 31, 2024 -2,189.77%
Dec 31, 2023 -1,492.99%
Sep 30, 2023 -747.09%
Jun 30, 2023 -1,475.59%
Mar 31, 2023 -2,794.61%
Dec 31, 2022 -3,813.87%
Sep 30, 2022 -18,291.04%
Jun 30, 2022 -5,217.30%
Mar 31, 2022 -3,904.74%
Dec 31, 2021 -208.02%
Sep 30, 2021 -1,156.20%
API Access

Insight Molecular Diagnostics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=IMDX&period=max&api_key=YOUR_API_KEY